𝔖 Bobbio Scriptorium
✦   LIBER   ✦

IgG-Paraoxonase-1 Fusion Protein for Targeted Drug Delivery across the Human Blood−Brain Barrier

✍ Scribed by Boado, Ruben J.; Zhang, Yun; Zhang, Yufeng; Wang, Yuntao; Pardridge, William M.

Book ID
127001821
Publisher
American Chemical Society
Year
2008
Tongue
English
Weight
256 KB
Volume
5
Category
Article
ISSN
1543-8384

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GDNF fusion protein for targeted-drug de
GDNF fusion protein for targeted-drug delivery across the human blood–brain barrier
✍ Ruben J. Boado; Yun Zhang; Yufeng Zhang; Yuntao Wang; William M. Pardridge 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

## Abstract Glial‐derived neurotrophic factor (GDNF) is a neurotrophin that could be developed as a neurotherapeutic for Parkinson's disease, stroke, and motor neuron disease. However, GDNF does not cross the blood–brain barrier (BBB). Human GDNF was re‐engineered by fusion of the mature GDNF prote

Genetic engineering of a lysosomal enzym
Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier
✍ Ruben J. Boado; Yun Zhang; Yufeng Zhang; Chun-fang Xia; Yuntao Wang; William M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

## Abstract Mucopolysaccharidosis Type I, Hurler's Syndrome, is a lysosomal storage disorder that affects the brain. The missing enzyme, α‐L‐iduronidase (IDUA), does not cross the blood‐brain barrier (BBB). To enable BBB transport of the enzyme, human IDUA was fused to the carboxyl terminus of the

Humanization of anti-human insulin recep
Humanization of anti-human insulin receptor antibody for drug targeting across the human blood–brain barrier
✍ Ruben J. Boado; Yufeng Zhang; Yun Zhang; William M. Pardridge 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

## Abstract A murine monoclonal antibody (MAb) to the human insulin receptor (HIR) has been engineered for use as a brain drug delivery system for transport across the human blood–brain barrier (BBB). The HIRMAb was humanized by complementarity determining region (CDR) grafting on the framework reg